Hamilton-Davies C, Barclay G R, Murphy W G, Machin S J, Webb A R
Department of Intensive Care Medicine, University College London Hospitals, Middlesex Hospital, UK.
Vox Sang. 1996;71(3):165-9. doi: 10.1046/j.1423-0410.1996.7130165.x.
Postoperative complications have been associated with low pre-operative endotoxin core antibody (EndoCAb) status. Seventy-three patients scheduled to undergo elective cardiac surgery were screened for IgG EndoCAb levels 1 week prior to admission. Of these 73 patients, 39 had levels below the median of a healthy population (100 MU = median units/ml). Only 6 received an infusion of IgG EndoCAb hyperimmune fresh frozen plasma (FFP) due to surgical rescheduling or unavailability of compatible hyperimmune FFP. The 6 patients demonstrated significant elevation (p < 0.0001) of their IgG EndoCAb levels from a mean level of 43 MU/ml (range: 26-75) to a posttransfusion mean of 267 MU/ml (range: 227-300), which persisted until at least immediately prior to the operative period. We conclude that passive immunisation with EndoCAb hyperimmune FFP is possible prior to elective surgery and that the kinetic profile of such an administration will allow the FFP to be given the night prior to surgery and still maintain significantly elevated levels for surgery planned the following morning.
术后并发症与术前内毒素核心抗体(EndoCAb)水平较低有关。对73例计划接受择期心脏手术的患者在入院前1周筛查了IgG EndoCAb水平。在这73例患者中,39例的水平低于健康人群的中位数(100 MU =中位数单位/毫升)。由于手术重新安排或缺乏相容的超免疫新鲜冰冻血浆(FFP),只有6例接受了IgG EndoCAb超免疫FFP输注。这6例患者的IgG EndoCAb水平从平均43 MU/毫升(范围:26 - 75)显著升高(p < 0.0001)至输血后平均267 MU/毫升(范围:227 - 300),且至少持续到手术期即将开始前。我们得出结论,在择期手术前用EndoCAb超免疫FFP进行被动免疫是可行的,并且这种给药的动力学特征将允许在手术前一晚给予FFP,并且在第二天上午计划的手术时仍保持显著升高的水平。